Beta Drugs Cash Flow Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,180.10 -36.10 (-2.97%)Updated : 19 May 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 124.47 | -4.67 | -0.06 | 1.82 |
| Net Changein Cash | 118.39 | 9.47 | 1.84 | 6.90 |
| Net Income/ Starting Line | 61.54 | 48.75 | 41.06 | 34.30 |
| Changesin Working Capital | -19.03 | -13.58 | -19.69 | -9.77 |
| Cashfrom Operating Activities | 36.14 | 30.93 | 23.38 | 29.63 |
| Cash Interest Paid | 6.99 | 2.82 | 2.41 | 1.90 |
| Cashfrom Financing Activities | 117.97 | -7.49 | -2.47 | -0.97 |
| Issuance( Retirement)of Stock Net | 0.48 | - | 0.00 | 0.00 |
| Depreciation/ Depletion | 12.51 | 9.78 | 10.41 | 7.25 |
| Other Investing Cash Flow Items Total | 1.14 | -2.36 | -0.86 | -2.33 |
| Capital Expenditures | -36.86 | -11.62 | -18.21 | -19.43 |
| period Type | - | - | - | - |
| Non- Cash Items | -18.88 | -14.03 | -8.39 | -2.16 |
| Financing Cash Flow Items | -6.99 | -2.82 | -2.41 | -2.80 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -35.72 | -13.97 | -19.07 | -21.75 |
*All figures in crores except per share values
Beta Drugs Quick Links
Beta Drugs Dividend Beta Drugs Bonus Beta Drugs News Beta Drugs AGM Beta Drugs Rights Beta Drugs Splits Beta Drugs Board Meetings Beta Drugs Key Metrics Beta Drugs Shareholdings Beta Drugs Profit Loss Beta Drugs Balance Sheet Beta Drugs Q1 Results Beta Drugs Q2 Results Beta Drugs Q3 Results Beta Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
362.35+23.50(6.94%)
1,122.90+27.30(2.49%)
1,816.90+43.70(2.46%)
1,337.00-24.75 (-1.82%)
4,055.95-74.25 (-1.80%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.